Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Med Virol ; 88(9): 1487-96, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-26864280

RESUMO

To investigate whether the administration of IL-12 is effective against influenza virus infection, mice were intranasally administered IL-12 for three consecutive days and then infected with a non-lethal dose of the influenza virus. The IL-12-treated mice were more resistant to the virus than control mice with respect to the remission of body weight loss, virus burden, pro-inflammatory cytokine production, and inflammatory cell infiltration in the lungs. The number of NK cells and the level of NK cell cytotoxicity significantly increased in the lungs of the mice treated with IL-12 before infection compared to that observed in control mice, leading to promptly eliminate the viral-infected cells. Unexpectedly, all of mice that received IL-12 treatment after being infected with a non-lethal dose of the virus died as a result of their high virus burden and pro-inflammatory cytokine production in the lungs. One possibility of the mechanisms was considered to be activation of myeloid-derived suppressor cell (MDSC), which has immune suppressive function, in the lungs. Thus, IL-12 treatment has opposite effects depending on whether it is administered before or after infection. These results demonstrate the potential risks of immune modulating therapies such as administration of exogenous cytokine or neutralization of cytokine. J. Med. Virol. 88:1487-1496, 2016. © 2016 Wiley Periodicals, Inc.


Assuntos
Influenza Humana/tratamento farmacológico , Influenza Humana/prevenção & controle , Interleucina-12/administração & dosagem , Interleucina-12/efeitos adversos , Infecções por Orthomyxoviridae/prevenção & controle , Administração Intranasal , Animais , Citocinas/biossíntese , Citocinas/imunologia , Esquema de Medicação , Humanos , Inflamação/tratamento farmacológico , Inflamação/imunologia , Vírus da Influenza A Subtipo H1N1/imunologia , Influenza Humana/imunologia , Influenza Humana/virologia , Interleucina-12/uso terapêutico , Células Matadoras Naturais/imunologia , Pulmão/virologia , Camundongos , Camundongos Endogâmicos BALB C , Células Supressoras Mieloides/imunologia , Infecções por Orthomyxoviridae/tratamento farmacológico , Infecções por Orthomyxoviridae/imunologia , Infecções por Orthomyxoviridae/virologia
2.
Biochem Biophys Res Commun ; 434(4): 791-6, 2013 May 17.
Artigo em Inglês | MEDLINE | ID: mdl-23603257

RESUMO

The purpose of this study was to evaluate the effects of bovine lactoferrin against norovirus infection using mouse norovirus (MNV) and Raw264.7 cell in vitro. When Raw264.7 cells were infected with MNV in the presence or absence of lactoferrin, the cytotoxic damage to the infected Raw264.7 cells significantly and dose-dependently decreased and completely inhibited in the presence of 15 or 20 µg/well of lactoferrin as compared with the absence of lactoferrin. Correspondingly, the MNV titers in the culture medium and intracellularly were significantly decreased in infected Raw264.7 cells treated with lactoferrin compared to control infected Raw264.7 cells. The mechanisms responsible for the protective effects of lactoferrin against MNV infection were attributed to both its inhibition of the initial MNV attachment to cells and the subsequent interference with MNV replication. Moreover, it was revealed that lactoferrin could rapidly induce the expression of anti-viral cytokine mRNA, such as IFN-α and IFN-ß which involved in inhibition of MNV replication in infected Raw264.7 cells, in the early phase of infection. It was concluded that lactoferrin exerts protective effects against MNV infection through inhibition of both viral attachment and replication. The present results provide evidence that lactoferrin may be useful as a preventive and/or therapeutic anti-norovirus agent.


Assuntos
Lactoferrina/farmacologia , Macrófagos/efeitos dos fármacos , Norovirus/crescimento & desenvolvimento , Ligação Viral/efeitos dos fármacos , Replicação Viral/efeitos dos fármacos , Animais , Anti-Infecciosos/farmacologia , Anticorpos Neutralizantes/imunologia , Anticorpos Neutralizantes/farmacologia , Bovinos , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/genética , Relação Dose-Resposta a Droga , Expressão Gênica/efeitos dos fármacos , Interações Hospedeiro-Patógeno/efeitos dos fármacos , Interferon-alfa/genética , Interferon-alfa/imunologia , Interferon beta/genética , Interferon beta/imunologia , Macrófagos/metabolismo , Macrófagos/virologia , Camundongos , Norovirus/genética , Norovirus/fisiologia , RNA Viral/genética , RNA Viral/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Tempo
3.
J Clin Immunol ; 32(2): 256-67, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22134539

RESUMO

PURPOSE: This study was conducted in order to investigate whether the virulence of the influenza virus infection is affected by asthma in mice. METHODS: Mice with asthma or control mice were infected with influenza virus. The survival rate, body weight, virus titer, cytokine profile, and cell infiltration in bronchoalveolar lavage fluid (BALF) were measured. The NK cell cytotoxicity was determined by a co-culture system with YAC-1 cells, and the effects of NK cells were observed by depletion of NK cells using anti-asialoGM1 serum. The virus-specific CD8(+) T cell killing assay was also performed. RESULTS: When asthmatic or control mice were infected with non- and sub-lethal doses of influenza virus, the asthmatic mice were more resistant to the virus than control mice with regard to the survival rate, the remission of body weight loss, and the virus burden. Anti-viral cytokines and the NK cell number were increased in the BALF of asthmatic mice before the infection. The NK cell cytotoxicity in the asthmatic mice was significantly enhanced compared to that in control mice, and the depletion of NK cells in asthmatic mice was abrogated both the improved survival rate and the recovery of the body weight loss. The antigen-specific CD8(+) T cell killing activity in asthmatic mice was also significantly increased following the infection compared to that in control mice. CONCLUSION: NK cell activated by the induction of asthma and the subsequently activated antigen-specific CD8(+) T cells could promptly eliminate the viral-infected cells, thus leading to improvements in the morbidity and mortality of influenza virus infection.


Assuntos
Asma/complicações , Asma/imunologia , Células Matadoras Naturais/imunologia , Ativação Linfocitária/imunologia , Infecções por Orthomyxoviridae/complicações , Infecções por Orthomyxoviridae/imunologia , Animais , Especificidade de Anticorpos , Asma/mortalidade , Líquido da Lavagem Broncoalveolar/citologia , Líquido da Lavagem Broncoalveolar/imunologia , Linfócitos T CD8-Positivos/imunologia , Movimento Celular/imunologia , Citocinas/biossíntese , Citotoxicidade Imunológica , Suscetibilidade a Doenças/imunologia , Feminino , Imunoglobulina E/sangue , Imunoglobulina E/imunologia , Interferon gama/biossíntese , Pulmão/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Infecções por Orthomyxoviridae/prevenção & controle , Baço/imunologia
4.
J Infect Chemother ; 17(2): 214-8, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20714914

RESUMO

The BD geneOhm MRSA™ assay has been increasingly used in recent years, and it is possible to use it to screen and detect methicillin-resistant Staphylococcus aureus (MRSA) from a specimen within 2 h. The purpose of the present study was to evaluate the performance, i.e., the specificity and sensitivity, of the BD geneOhm MRSA™ assay to detect MRSA. Its specificity was assessed to be 100% compared to bacterial culture methods, which are commonly used in medical laboratories. Its bacterial limit of detection was over 10 colony-forming units (cfu) per reaction, although MRSA was detected at a cfu below 10 per reaction in a few samples. Additionally, the effect of MRSA isolate contamination was examined. While contamination with protein or other bacteria did not affect the outcome, contamination with a high concentration of blood resulted in an unresolved outcome. To inactivate polymerase chain reaction (PCR) inhibitors, the DNA samples were freeze-thawed prior to the BD geneOhm MRSA™ assay, which led to the sensitivity of the assay increasing. In summary, the BD geneOhm MRSA™ assay is rapid and shows high specificity and sensitivity of cultured MRSA isolates. It will, therefore, be a valuable diagnostic tool for detecting MRSA in specimens from clinical patients.


Assuntos
Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Técnicas de Diagnóstico Molecular/métodos , Reação em Cadeia da Polimerase/métodos , Infecções Estafilocócicas/diagnóstico , Meios de Cultura , DNA Bacteriano/análise , DNA Bacteriano/genética , DNA Bacteriano/isolamento & purificação , Contaminação de Medicamentos , Humanos , Japão , Staphylococcus aureus Resistente à Meticilina/genética , Kit de Reagentes para Diagnóstico , Sensibilidade e Especificidade , Infecções Estafilocócicas/microbiologia
5.
Biosci Biotechnol Biochem ; 74(7): 1338-42, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20622449

RESUMO

The purpose of this study was to investigate the effects of heat-killed Lactobacillus plantarum strain b240 (b240) on systemic infection by Salmonella enterica serovar Typhimurium (S. Typhimurium) and to determine the mechanism by which b240 protects against infection. Mice were administered either b240 or saline orally for 3 weeks, and then inoculated with S. Typhimurium. The mice treated with b240 were significantly protected against S. Typhimurium as compared to those fed saline. Moreover, translocation of S. Typhimurium into each organ tested in the mice that received b240 tended to be less than in the control mice. An important mechanism of protection against infection was demonstrated by the ability of b240 to inhibit both binding by and invasion of S. Typhimurium into cells. These results indicate that nonviable lactic acid bacteria also play important roles in preventing infection by enteric pathogens.


Assuntos
Temperatura Alta , Lactobacillus plantarum/fisiologia , Infecções por Salmonella/prevenção & controle , Salmonella typhimurium/fisiologia , Administração Oral , Animais , Aderência Bacteriana , Feminino , Células HeLa , Humanos , Imunoglobulina A/biossíntese , Imunoglobulina A/metabolismo , Camundongos , Camundongos Endogâmicos C57BL
6.
Virology ; 499: 23-29, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27632562

RESUMO

The immunological mechanisms of secondary bacterial infection followed by influenza virus infection were examined. When mice were intranasally infected with influenza virus A and then infected with P. aeruginosa at 4 days after viral infection, bacterial clearance in the lung significantly decreased compared to that of non-viral infected mice. Neutrophils from viral infected mice showed impaired digestion and/or killing of phagocytized bacteria due to reduced myeloperoxidase (MPO) activity. G-CSF production in the lungs of viral infected mice was lower than that of non-viral infected mice after secondary bacterial infection. When viral infected mice were injected with G-CSF before secondary bacterial infection, the MPO activity of viral infected mice restored to the same level as that of non-infected mice. Bacteria clearance in viral infected mice was also recovered by G-CSF administration. Thus, neutrophil dysfunction caused by influenza virus is attributed to insufficient G-CSF production, which induces a secondary bacterial infection.


Assuntos
Coinfecção , Fator Estimulador de Colônias de Granulócitos/biossíntese , Vírus da Influenza A/imunologia , Neutrófilos/imunologia , Neutrófilos/metabolismo , Infecções por Orthomyxoviridae/imunologia , Infecções por Orthomyxoviridae/metabolismo , Pneumonia Bacteriana/etiologia , Animais , Carga Bacteriana , Citocinas/biossíntese , Feminino , Mediadores da Inflamação/metabolismo , Vírus da Influenza A Subtipo H1N1/imunologia , Camundongos , Infecções por Orthomyxoviridae/complicações , Infecções por Orthomyxoviridae/virologia , Peroxidase/metabolismo , Fagocitose/imunologia , Pneumonia Bacteriana/metabolismo , Pseudomonas aeruginosa/imunologia , Risco
7.
Virology ; 407(2): 325-32, 2010 Nov 25.
Artigo em Inglês | MEDLINE | ID: mdl-20855097

RESUMO

Natural killer T (NKT) cell activation is responsible for eliminating pathogens. However, the biological functions of NKT cells against influenza virus are not fully understood. We therefore investigated the effects of NKT cells in viral infection using CD1d knockout (KO) mice. When CD1d KO or wild-type (WT) mice were infected with a sub-lethal dosage of the influenza virus, the survival rate of CD1d KO mice was significantly lower than for WT mice in association with delayed viral clearance in the lungs. Consistently, IFN-γ production in bronchoalveolar lavage fluid of CD1d KO mice was largely reduced compared to WT mice during infection. Moreover, the cytotoxic activities of NK cells and viral antigen-specific CD8(+) T cells were impaired in CD1d KO mice. It was concluded that activated NKT cell-induced IFN-γ release enhances both NK-cell activity and antigen-specific CD8(+) T cells to eliminate the influenza virus, thus leading to an enhanced survival.


Assuntos
Linfócitos T CD8-Positivos/imunologia , Vírus da Influenza A Subtipo H1N1/patogenicidade , Interferon gama/biossíntese , Células Matadoras Naturais/imunologia , Ativação Linfocitária/imunologia , Células T Matadoras Naturais/imunologia , Infecções por Orthomyxoviridae/imunologia , Animais , Antígenos CD1d/genética , Antígenos CD1d/imunologia , Antígenos CD1d/metabolismo , Líquido da Lavagem Broncoalveolar/imunologia , Citotoxicidade Imunológica , Feminino , Vírus da Influenza A Subtipo H1N1/imunologia , Células Matadoras Naturais/citologia , Pulmão/virologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Knockout , Infecções por Orthomyxoviridae/mortalidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA